Pillar Invest Corp insider trades: Aceragen (ACGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pillar Invest Corp reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | ACGN | ↓ Sell | 5,818 | $1.56 | $9K | Indirect | Jul 19, 2023 (6d) |
| May 17, 2023 | ACGN | ↑ Buy | 26,965 | $1.42 | $38K | Indirect | Jul 19, 2023 (63d) |
| Mar 18, 2021 | IDRA | ↓ Sell | 1,376,039 | $1.80 | $2.5M | Indirect | Mar 31, 2021 (13d) |
| Mar 18, 2021 | IDRA | ↓ Sell | 323,726 | $1.80 | $582K | By Pillar Pharmaceuticals 6, L.P. | Mar 31, 2021 (13d) |
| Dec 11, 2020 | IDRA | ↑ Buy | 69,941 | $1.82 | $127K | Indirect | Dec 15, 2020 (4d) |
| Jul 13, 2020 | IDRA | ↑ Buy | 749,993 | $1.72 | $1.3M | Indirect | Jul 15, 2020 (2d) |
| Apr 7, 2020 | IDRA | ↑ Buy | 3,039,514 | $1.52 | $4.6M | Indirect | Apr 9, 2020 (2d) |
| Jan 29, 2020 | IDRA | ↓ Sell | 44,782 | $1.77 | $79K | Indirect | Feb 26, 2020 (28d) |
| Nov 8, 2019 | IDRA | ↓ Sell | 119,000 | $2.49 | $296K | Indirect | Nov 8, 2019 (0d) |
| Aug 9, 2018 | IDRA | ↓ Sell | 300,000 | $5.80 | $1.7M | Indirect | Aug 17, 2018 (8d) |
| Jul 20, 2018 | IDRA | ↓ Sell | 2,773,567 | $0.86 | $2.4M | Indirect | Jul 24, 2018 (4d) |
| Jul 17, 2018 | IDRA | ↓ Sell | 1,860,776 | $1.01 | $1.9M | Indirect | Jul 19, 2018 (2d) |
| Jan 17, 2018 | IDRA | ↓ Sell | 200,000 | $2.40 | $480K | Indirect | Jan 19, 2018 (2d) |
| Dec 15, 2017 | IDRA | ↓ Sell | 2,300,000 | $1.96 | $4.5M | Indirect | Dec 15, 2017 (0d) |
| May 1, 2017 | IDRA | ↓ Sell10b5-1 | 450,815 | $2.26 | $1.0M | Indirect | May 3, 2017 (2d) |
| Apr 25, 2017 | IDRA | ↓ Sell10b5-1 | 1,328,422 | $2.29 | $3.0M | Indirect | Apr 26, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Pillar Invest Corp's insider trades
Pillar Invest Corp is a 10% owner of Aceragen (ACGN). Since Apr 25, 2017, it has reported 4 open-market purchases worth $6.1M and 12 sales worth $18.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (22% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Its filings also include option exercises (13 filings), other transactions (5 filings), conversions (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.